Banner
Late-Breaking Analysis In Hypertension Shows That Antihypertensive Treatments Differ In Their Ability To Preserve Lives

STOCKHOLM, August 30, 2010 /PRNewswire/ -- According to the results of a late-breaking analysis...

Clinical Results For New Treatment Of Bacterial Vaginosis Infection

The Swedish company Laccure AB recently got CE marking as a Class IIa medical device product for...

88 Percent Of UK Doctors Believe Whiplash Claims Are Exaggerated

AXA, a UK car insurer, has surveyed UK doctors as part of its ongoing campaign to understand the...

On Facebook, Women Are More Plentiful But Men Are Better Ad Targets

Global digital marketing companies Resolution Media and Kenshoo Social published a new report today...

User picture.
Anna OhldenRSS Feed of this column.

Media Relations Executive, PR Newswire Europe... Read More »

Blogroll

READING, England and SAN MATEO, California, August 5 /PRNewswire/ --

- Touchline Video's Extensive Channel Network Adds Avistar Technology as Users See Real Cost and Time Benefits of C3 Standards-Based Desktop Solution

MINNEAPOLIS, August 5 /PRNewswire/ --

Since IISP announced the Certified Software Process Improvement Professional (CSPIP) program last March, we have received an overwhelming number of inquiries from organizations and individuals in different countries regarding the new certification.

MEXICO CITY, August 5 /PRNewswire/ --

- HIV-Infected Women and Non-Whites New to Antiretroviral Therapy Respond Similarly to Men and Whites

Initial treatment regimens containing once-daily or twice-daily dosing of Abbott's (NYSE: ABT) protease inhibitor Kaletra(R) (lopinavir/ritonavir) tablet provided similar results for controlling the virus (reducing the amount of HIV-1) and improving the immune system (increasing CD4 cells) in women compared to men and in non-whites compared to whites, according to 48-week data presented by Abbott today at the XVII International AIDS Conference (AIDS 2008).

HAIFA, Israel, August 5 /PRNewswire/ -- Oil Refineries Ltd. (TASE: ORL.TA) (the "Company"), Israel's largest oil refiner, announced today that, further to the Company's release of June 4, 2008 regarding signing of the Second letter of Undertaking by Israel Corporation Company ("Israel Corporation") vis-a-vis Israel Petrochemicals Enterprises Ltd. ("IPE") and Petroleum Capital Holdings Ltd. ("Petroleum") ("Second letter of Undertaking"), the Israel corporation has issued an immediate report regarding the signing of a third letter of undertaking vis-a-vis IPE and Petroleum ("Third Letter of Undertaking"). A full convenient translation of the said immediate report is available in the Company's website, http://www.orl.co.il, under "Investor Relation".

BRISTOL, England, August 5 /PRNewswire/ --

EBL and Mallory International are delighted to announce a joint initiative to promote and develop the sale and access of ebooks into libraries in Africa. Innovative pricing and delivery models, appropriate to the region, are being developed jointly, to give institutions effective access to the latest content and ebook technology.

SAN MATEO, California, August 5 /PRNewswire/ --

- NetSuite Supports Intuitive Surgical's Rapid Growth Nestle UK Builds Online Store with NetSuite Ecommerce in Six Weeks Wasserman Replaces Microsoft Dynamics-Great Plains with NetSuite For ERP and CRM